Company Description
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.
It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism.
It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals.
The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014.
BioCorRx Inc. is based in Anaheim, California.
| Country | United States |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Ms. Lourdes Felix |
Contact Details
Address: 2390 East Orangewood Avenue, Suite 500 Anaheim, California 92806 United States | |
| Phone | (714) 462-4880 |
| Website | biocorrx.com |
Stock Details
| Ticker Symbol | BICX |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001443863 |
| CUSIP Number | 09073C205 |
| ISIN Number | US09073C2052 |
| Employer ID | 90-0967447 |
| SIC Code | 8093 |
Key Executives
| Name | Position |
|---|---|
| Lourdes Felix | Chief Executive Officer, Chief Financial Officer and Director |
| Brady James Granier | President and Director |
| Thomas Patrick Welch | Executive Vice President |
| Dr. George N. Fallieras | Medical Consultant |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2024 | 8-K | Current Report |
| Apr 1, 2024 | 10-K | Annual Report |
| Jan 5, 2024 | 8-K | Current Report |
| Dec 15, 2023 | 8-K | Current Report |
| Nov 16, 2023 | 8-K | Current Report |
| Nov 14, 2023 | 10-Q | Quarterly Report |
| Nov 2, 2023 | 8-K | Current Report |
| Aug 14, 2023 | 10-Q | Quarterly Report |
| May 15, 2023 | 10-Q | Quarterly Report |
| Apr 11, 2023 | 8-K | Current Report |